Injective INJ
Current Price
$3.76 +6.20%
$0.5700 Daily Range (15.16%)
$3.51$4.08
$155.49M Daily Volume
1,989 BTC
Vol/MktCap: 41.29%
Market Performance
0.70% Relative BTC Volume
The total volume of Injective is $155.49M over the past 24 hours, compared to $22.24B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.66 +2.71%
13 SMA $3.69 +1.79%
21 SMA $3.64 +3.41%
55 SMA $3.55 +5.99%
144 SMA $3.41 +10.42%
Price Performance
+2.03% 1 Hour Change
$3.76 from $3.69
+16.38% 7 Day Change
$0.6158 from $3.14
+29.09% 14 Day Change
$1.09 from $2.67
+31.08% 30 Day Change
$1.17 from $2.59
All Time High
March 14, 2024
$52.62 -92.85%
-$48.86 vs. now
24H Change
22.65M USD +6.40%
290 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
40.97M INJ
traded over past 24 hours
40.97% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.79, reflecting a 7.32% increase over the past 24 hours. The daily trading range has been between $3.51 and $4.08, indicating significant volatility that can attract traders looking for short-term opportunities.
The volume of 155,155,015 represents 40.99% of the market cap, suggesting strong interest and liquidity in the current market. The 1-hour RSI stands at 65, indicating the asset is approaching overbought territory, while the 7-day RSI at 58 suggests a more neutral stance over the longer term.
Short-term moving averages show a bullish trend, with the 8 SMA at $3.66 (+3.53%) and the 13 SMA at $3.69 (+2.61%). The longer-term 55 SMA at $3.55 (+6.83%) and 144 SMA at $3.41 (+11.30%) confirm an upward trajectory, signaling potential for continued price appreciation if momentum holds.
In terms of price performance, INJ has shown strong gains with a 7-day change of 16.93%, a 14-day increase of 29.27%, and a 30-day rise of 31.60%. This upward trend is supported by solid trading volume and market participation, which may indicate growing investor confidence in Injective.
Given the current technical indicators, particularly the bullish moving averages and the substantial price increases over multiple time frames, the outlook for INJ appears positive. However, the elevated 1-hour RSI suggests caution for short-term traders, as a pullback could occur.
Based on the analysis of both technical indicators and price performance, a Buy rating is recommended for Injective (INJ) at the current price level. The strong upward momentum and trading volume indicate potential for further gains, though investors should monitor for signs of overextension.
The volume of 155,155,015 represents 40.99% of the market cap, suggesting strong interest and liquidity in the current market. The 1-hour RSI stands at 65, indicating the asset is approaching overbought territory, while the 7-day RSI at 58 suggests a more neutral stance over the longer term.
Short-term moving averages show a bullish trend, with the 8 SMA at $3.66 (+3.53%) and the 13 SMA at $3.69 (+2.61%). The longer-term 55 SMA at $3.55 (+6.83%) and 144 SMA at $3.41 (+11.30%) confirm an upward trajectory, signaling potential for continued price appreciation if momentum holds.
In terms of price performance, INJ has shown strong gains with a 7-day change of 16.93%, a 14-day increase of 29.27%, and a 30-day rise of 31.60%. This upward trend is supported by solid trading volume and market participation, which may indicate growing investor confidence in Injective.
Given the current technical indicators, particularly the bullish moving averages and the substantial price increases over multiple time frames, the outlook for INJ appears positive. However, the elevated 1-hour RSI suggests caution for short-term traders, as a pullback could occur.
Based on the analysis of both technical indicators and price performance, a Buy rating is recommended for Injective (INJ) at the current price level. The strong upward momentum and trading volume indicate potential for further gains, though investors should monitor for signs of overextension.
Updated 83 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Market conditions force 1 in 3 crypto traders to cut everyday spending: Survey
More than a third of US crypto traders report cutting daily expenses and delaying major purchases as unrealized losses weigh on household finances.

Iran conflict disrupts oil supply, Strait of Hormuz closure impacts markets
The disruption highlights global energy vulnerabilities, prompting potential strategic shifts and increased geopolitical tensions in oil markets.

Miners Beat Bitcoin by 70% in 2026 as Terawulf Locks $12.8B in AI Contracts
The bitcoin mining and digital infrastructure sector has had a split personality through the first four months of 2026.

Tillis backs Warsh for Fed Chair as DOJ drops Powell probe
The shift in support and market odds highlights the dynamic nature of political endorsements and their impact on financial predictions.